The Society for Cardiovascular Angiography and Interventions (SCAI) announced that a multisociety expert consensus statement ...

ICU patients with a central venous access device had a smaller incidence rate of device-related complications with 4% ...

Catheter Precision, Inc. VTAK shares plummeted on Friday as traders reversed part of the stock’s recent headline-driven gains ...

With the acquisition of Robocath completed, Stereotaxis intends to accelerate development of next-generation robotic ...

Johnson & Johnson expects U.S. physicians to perform the first procedures with the device this summer as it starts a phased ...

Nectero Therapeutics announced the 2-year findings from a first-in-human (FIH) multicenter study evaluating treatment of small- to ...

Nectero Therapeutics announced today a first-in-human (FIH) multicenter study evaluated treatment of small- to medium-sized abdominal aortic aneurysms (AAA) with pentagalloylglucose (PGG) using its ...

Syracuse, N.Y. — A Syracuse medical device startup that has spent nearly a decade developing a reusable system for people who use catheters has received federal clearance to begin selling its product.

Encouraging 12-month pilot clinical study results will be presented by Key Opinion Leader Dr. Lowell Kabnick at the prestigious Charing Cross Vascular Symposium in London on Tuesday, April 21st, 2026.

Junkosha has chosen MD&M West in Anaheim CA, this week to launch an expanded range of its etched PTFE catheter liners to support the evolving needs of the peripheral vascular market. The company now ...